跳到主要內容
:::

林倩伃 醫師

頭頸部腫瘤、鼻咽癌

教職 : 副教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 林口長庚醫院放射腫瘤科主治醫師

學歷

  • 2005.06-2012.02 長庚大學臨床醫學研究所 博士
  • 2004.07-2005.06 長庚大學臨床醫學研究所 碩士
  • 1991.09-1998.06 畢業於中山醫學院

經歷

  • 2015~2020 兼任助理教授, 長庚大學 醫放系
  • 2010~2015 兼任講師, 長庚大學 醫放系
  • 2002~2008 助理教授級主治醫師, 林口長庚醫院放射腫瘤科
  • 2002~2008 講師級主治醫師, 林口長庚醫院放射腫瘤科
  • 2002~2008 一般級主治醫師, 林口長庚醫院放射腫瘤科
  • 2003~2003 主任醫師, 借調苗栗為恭醫院放射腫瘤科
  • 2003~2003 主任醫師, 借調羅東博愛醫院放射腫瘤科
  • 2001~2002 總住院醫師, 林口長庚醫院放射腫瘤科
  • 1998~2001 住院醫師, 林口長庚醫院放射腫瘤科

學會與認證

  • 2012年11月03日人體試驗研究人員講習班,共8小時(內含認證考試及格2小時)
  • 美國癌症研究學會
  • 美國放射腫瘤學會
  • 台灣放射腫瘤學會

論文及期刊發表

  • Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma.
  • Precision Adjuvant Therapy Based on Detailed Pathological Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long Term Outcome Comparison of CGMH and NCCN Guidelines.
  • Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma.
  • Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
  • Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.
  • Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience.
  • Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy.
  • Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
  • Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma.
  • Outcome Analyses of Unusual Site Neck Recurrence in Oral Cavity Cancer.
  • Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
  • GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
  • Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer.
  • Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced stage oral cavity cancers.
  • Positive association of GRP78 during oral cancer progression and the prognostic value in oral precancer lesions.
  • Treatment outcome of combined modalities for buccal cancers - unilateral or bilateral neck radiation?
  • Junction techniques for pharynx and neck treatment.
  • Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
  • Development and evaluation of a computerized clinical outcome assessment tool for head and neck cancer patients.
  • Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
  • Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma.
  • Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma.
  • Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
  • Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial.
  • A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.
  • Tumor Depth of Invasion (Tumor?>?4 cm/Depth?>?10 mm and Depth?>?20 mm) and Through Cortex/Skin Invasion are Both Valid Criteria for Classifying Tumors as pT4a in AJCC 2018 Oral Cavity Cancer Staging System. �
  • Impact of physical and psychosocial dysfunction on return to work in survivors of oral cavity cancer.
  • High metastatic node number, not extranodal extension, as a node-related prognosticator in surgically treated patients with nodal metastatic salivary gland carcinoma.
  • Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
  • Swallowing ability and its impact on dysphagia-specific health-related QOL in oral cavity cancer patients post-treatment.
  • Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.
  • Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.
  • Life quality improvement in hoarse patients with early glottic cancer after transoral laser microsurgery.
  • Psychosocial Effects of a Skin Camouflage Program in the Female Survivors with Head and Neck Cancer: A Randomized Controlled Trial.
  • Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study.
  • Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?
  • Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.
  • Psychosocial Effects of a Skin Camouflage Program in the Female Survivors with Head and Neck Cancer: A Randomized Controlled Trial.
  • What should we expect from robotic surgery for second primary oropharyngeal cancer?
  • Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures. Health.
  • Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.
  • Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas.
  • Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
  • Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients.
  • Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
  • Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
  • An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a long-term follow-up result.
  • Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings.
  • Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
  • Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
  • Proteomics Analysis Reveals Involvement of Krt17 in Areca Nut-Induced Oral Carcinogenesis.
  • Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
  • Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings.
  • Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
  • Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
  • Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area.
  • RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study.
  • Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma.
  • An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
  • Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
  • Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.
  • Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer.
  • Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies.
  • Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment.
  • Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma.
  • The role of elective neck dissection in early stage buccal cancer.
  • Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation.
  • Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma.
  • Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area.
  • Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx.
  • Unmet supportive care needs and characteristics of family caregivers of patients with oral cancer after surgery.
  • Priority of fibular reconstruction in patients with oral cavity cancer undergoing segmental mandibulectomy.
  • Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular images.
  • Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
  • Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.
  • Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
  • Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
  • Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
  • Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes.
  • Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy.
  • Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
  • Supportive care needs in newly diagnosed oral cavity cancer patients receiving radiation therapy.
  • Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma.
  • Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
  • Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.
  • Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
  • Outcome Analyses of Unusual Site Neck Recurrence in Oral Cavity Cancer.
  • The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity.
  • Prognostic value of pretreatment (18)F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
  • Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients.
  • Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Levels.
  • Transoral Laser Microsurgery Elevates Fundamental Frequency in Early Glottic Cancer.
  • Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma.
  • Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.
  • Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
  • Identification of a High-Risk Group Among Patients With Oral Cavity Squamous Cell Carcinoma and pT1-2N0 Disease.
  • Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.
  • The Number of Pathologically Positive Lymph Nodes and Pathological Tumor Depth Predicts Prognosis in Patients with Poorly Differentiated Squamous Cell Carcinoma of the Oral Cavity.
  • Outcome Analysis of Patients with Oral Cavity Cancer and Extracapsular Spread in Neck Lymph Nodes.
  • Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
  • GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
  • Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy.
  • (18)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
  • Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer.
  • PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
  • Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity.
  • PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity.
  • Tongue and Buccal Mucosa Carcinoma: Is There a Difference in Outcome?
  • Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced stage oral cavity cancers.
  • Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.
  • Proteomics of the Radioresistant Phenotype in Head-and-Neck Cancer: Gp96 As a Novel Prediction Marker and Sensitizing Target for Radiotherapy.
  • Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
  • Positive association of GRP78 during oral cancer progression and the prognostic value in oral precancer lesions.
  • Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
  • Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma.
  • Outcome Analysis of Patients with pN2 Oral Cavity Cancer.
  • Transdermal Fentanyl for Pain Caused by Radiotherapy in Head and Neck Cancer Patients Treated in an Outpatient Setting: A Multicenter Trial in Taiwan.
  • 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
  • Hypothyroidism after radiotherapy for nasopharyngeal cancer patients.
  • Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer.
  • Radiation Therapy for Advanced Hepatocellular Carcinoma with Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin after Radiotherapy .
  • Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18) F-FDG PET and extended-field multi-detector row CT.
  • Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.
  • Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N).
  • Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value.
  • Treatment outcome of combined modalities for buccal cancers - unilateral or bilateral neck radiation?
  • Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection.
  • 18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma.
  • Health-related quality of life and patient satisfaction after treatment for breast cancer in northern Taiwan.
  • Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15.
  • Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
  • Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
  • Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
  • 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity modulated radiation technique for stage T4 nasopharyngeal carcinoma.
  • Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
  • The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
  • Nasopharyngeal carcinoma staging PDG PET.
  • Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
  • Presence of the latent membrane protein 1 Gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
  • The Effect of Fixed Couch-Isocenter Distance Treatment on Radiotherapy in Rectal Cancer Patients.
  • The outcome of patients with nasopharyngeal carcinoma treated with suboptimal radiation dose.
  • Intracavity Brachytherapy for nasopharyngeal carcinoma with Rotterdam Nasopharyngeal Applicator.
  • Junction techniques for pharynx and neck treatment. Th
長庚醫院智能服務 有任何問題隨時找我!